...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Pharmacoeconomics of allergic rhinitis drugs treatment in tertiary care hospital
【24h】

Pharmacoeconomics of allergic rhinitis drugs treatment in tertiary care hospital

机译:三级医院过敏性鼻炎药物治疗的药物经济学

获取原文
           

摘要

Background: Allergic rhinitis also called hay fever; it is a very common in India. Harmless exposing substances cause an allergic reaction. Allergic rhinitis is of the two types, one is the seasonal occurred with the change of seasons, second is the perennial means any time during the year. Methods: This was a cross-sectional study to determine the cost analysis allergic rhinitis drugs used in treatment of ENT OPD in a tertiary care teaching hospital, Kamothe, Navi Mumbai. The patients were interviewed; prescriptions were analyzed number of medicines prescribed. Results: Incidence of polypharmacy two drugs per prescriptions were prescribed 140 and three drugs per prescriptions 60. In the total number of 200 prescriptions, the cost of 43 prescriptions were in between 251-300 Indian rupees and 18 prescriptions were 301-350 Indian rupees. Patient knowledge about the drug use in this study, out of 200 pts 37% of allergic rhinitis patients knew the correct dosage of the prescribed drugs while 63% were not aware. Conclusions: Majority of the participants drugs were prescribed two to three drugs, per prescription cost was high because all the drugs prescribed by brand name and no drugs were prescribed by generic name. Improvement in knowledge about generic medicines is important factor to prefer generic medicine. Reduction in cost of drug will improve compliance.
机译:背景:过敏性鼻炎也称为花粉症;这在印度很常见。无害的暴露物质会引起过敏反应。过敏性鼻炎有两种类型,一种是季节性随季节变化而发生,第二种是常年性,指一年中的任何时间。方法:这是一项横断面研究,目的是确定在孟买新罕布什尔州卡莫泰市的一家三级教学医院中用于治疗ENT OPD的过敏性鼻炎药物的成本分析。患者接受了采访;处方被分析了处方药的数量。结果:多药房每处方开出两种药物的处方为140种,每处方开出三种药物的处方为60种。在200个处方的总数中,43个处方的成本在251-300印度卢比之间,而18个处方的成本在301-350印度卢比之间。在这项研究中,患者对药物使用的了解程度,在200分患者中,有37%的过敏性鼻炎患者知道处方药的正确剂量,而63%的患者不知道。结论:大多数参加者的药物被开处方两到三种药物,每张处方的费用很高,因为所有药物都是以商标名称开具的,而没有药物是由通用名称开具的。关于仿制药的知识的提高是偏爱仿制药的重要因素。降低药品成本将提高依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号